acids signal to mTORC1 through two Ras-related guanosine triphosphatases 48 (GTPases) (8, 9) . When amino acids are abundant, the heterodimeric Rag GTPases 49 adopt an active state and promote the recruitment of mTORC1 to the lysosomal 50 surface (10), which is now recognized as a key subcellular organelle involved in 51 mTORC1 regulation (11). Several essential amino acids in the lysosomal lumen 52 including arginine, leucine and glutamine have been identified as effective activators 53 of mTORC1 (12-15). However, the molecular basis of the amino acids sensing 54 mechanism has remained, by and large, elusive. Recently, SLC38A9, a low-affinity 55 arginine transporter on lysosome vesicles, was identified as a direct sensor of lumen 56 arginine levels for the mTORC1 pathway (16) (17) (18) . SLC38A9 also mediates the efflux 57 of essential amino acids from lysosomes, such as leucine, in an arginine regulated 58 manner (19) , to drive cell growth by modulating cytosolic sensors (20, 21) . Moreover, 59 SLC38A9 senses the presence of luminal cholesterol and activates mTORC1 60 independently of its arginine transport (22) . 61 62 SLC38A9 is a transceptor. Studies showed that two parts of SLC38A9, its N-terminal 63 domain and its transmembrane bundle, are responsible for two distinct functions. The 64 bulk of SLC38A9 are 11 alpha helices that pack against one another forming a 65 transmembrane bundle that transports amino acids and function as an amino acid 66 transporter (23). The N-terminus of SLC38A9, om the other hand, was previously 67 shown to interact directly with the Rag-Regulator complex to activate mTORC1 (16). 68
Collectively, these results suggest that SLC38A9 is a "transceptor", which is 69 membrane protein that embodies the functions of both a transporter and a receptor 70 (23) (24) (25) (26) (27) . 71 72 Recently we solved the crystal structure of N-terminally truncated SLC38A9 from 73
Danio rerio (DN-drSLC38A9) with arginine bound (23). The substrate arginine was 74 observed deep in the transporter at a binding pocket consisting of residues from 75 TM1a, TM3 and TM8 of SLC38A9. Because the N-terminally truncated form of 76 SLC38A9 was used that initial study focused solely on the transporter function of 77 SLC38A9 and resulting structures could not inform on the signaling function of 78 SLC38A9. 79 80 Here we report a new crystal structure of drSLC38A9 with its N-terminus but without 81 the substrate arginine. Surprisingly, we found that part of the N-terminus formed a 82 beta hairpin that lodged itself deep in the transporter occupying the arginine binding 83 site and blocking the transport path. These new results suggest that in the fed state the 84 N-terminal domain would be released from within SLC38A9 and freed to interact 85 with the Rag GTPase and activate mTORC1. We propose a ball-and-chain model to 86 describe this mechanism of amino acid sensation and signaling by SLC38A9. 87
88
In the present study we used the antibody fragment 11D3 to facilitate crystallization 89 of SLC38A9 in the absence of substrate. Well-ordered crystals were diffracted to ~3.4 90 Å with high completeness and acceptable refinement statistics (Table. S1 to Leu 91 ( fig. S3 ). This fragment formed a folded domain, resembling a beta hairpin, 102 filling the entire path from the cytosolic side of SLC38A9 to the substrate binding site 103 ( Fig. 1C ). Electrostatic potential analysis indicated that the transport pathway in 104 SLC38A9 is generally positively charged, while the N-terminal fragment (referred to 105 as the "N-plug" from this point on) is largely negatively charged ( fig. S4 ), suggesting 106 that the interaction is electrostatically driven. Deletion of the N-terminal domain of 107 drSLC38A9 did not affect arginine transport ( Fig. 1D ), indicating that the N-plug 108 does not directly participate in arginine translocation. 109
We captured SLC38A9 in a new state that we term the "N-plug inserted state". TMs 111 1, 5, 6 and 8 of SLC38A9 form a V-shaped cavity into which the N-plug inserts and is 112 stabilized by several bonds (Fig. 2) . At the tapered tip on the N-plug, Ser 80 and His 113 81 bound to the main-chain carbonyl oxygens of Thr 117, Met 118 and Met 119 in the 114 unwound region of TM1 ( Fig. 2A ). His 81 further stabilizes the tip region of the N-115 plug through a hydrogen bond between its imidazole side chain and Thr 121 ( All residues that participate in the inter-domain interactions are conserved across 125 species as indicated in the sequence alignments ( fig. S3 ), suggesting that this 126 interaction is evolutionarily conserved and likely plays an important functional role. 127
The beta-hairpin structure of the N-plug is also self-stabilized by several hydrogen 128 bonds between Ser 80 and Glu 82, His76 and Tyr 85 which fasten the two ends of the 129 N-plug together ( Fig. 2E ). Structural modeling by PEP-FOLD (28, 29) indicated that 130 the beta hairpin motif would be converted to an alpha helical fragment should these 131 residues were changed to alanines ( fig. S5 ). 132 133 SLC38A9 has higher affinity toward leucine than arginine although the transport of 134 leucine is largely facilitated by the presence of arginine (19). Uptake studies 135 performed here with drSLC38A9 corroborate the previous findings using the human 136 protein ( Fig. 3B ). Leucine uptake was significantly higher in the presence of 137 supplemented arginine than without. An overlay of the N-plug bound structure and 138 the arginine bound structure indicated that the same set of backbone atoms are used 139 for binding the N-plug and the arginine molecule ( Fig. 3A ). This superposition 140 suggests that in the presence of arginine the N-terminal plug may not occupy the 141 binding site, but that in the absence of arginine it would be free to insert and bind. Is it 142 possible, therefore, that in the presence of arginine the released N-terminal plug could 143 play an important role in facilitating leucine transport? 144 145 To examine whether the N-terminal plug plays an important role in facilitating leucine 146 transport, two drSLC38A9 variants were generated. One has residues 1-96 of N-147 terminus deleted (called N-truncated). The other has 5 key residues mutated (P79A, 148 S80A, H81A, E82A, and Y85A) in the N-plug (named 5A mutant) which would lead 149 to a disrupted secondary structure of the N-plug ( fig. S5 ). As observed in the uptake 150 study, both variants could transport arginine like the wild-type drSLC38A9 even with 151 the dramatic structural changes at the N-plug ( Fig. 1 D) . From the results of leucine 152 uptake by wild-type drSLC38A9, the arginine-enhanced transport of leucine is 153 reflected as increased uptake of [ 3 H]-leucine when the buffer was supplemented with 154 arginine. This characteristic of arginine-enhanced leucine transport was lost when the 155 N-plug was eliminated or its structure altered by mutation ( Fig. 3C and 3D ). Only the 156 SLC38A9 with intact N-terminal plug in its native beta hairpin like structure showed 157 the characteristic enhanced leucine uptake in the presence of supplemented arginine 158 Acknowledgements: 323 We thank D. Cawley for development and production of monoclonal antibodies; K. 324
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